Nyxoah (NYXH) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.402x

Based on the latest financial reports, Nyxoah (NYXH) has a cash flow conversion efficiency ratio of -0.402x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-20.48 Million ≈ $-23.95 Million USD) by net assets (€50.95 Million ≈ $59.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NYXH equity to assets ratio to measure how much of total assets are equity-financed.

Nyxoah - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Nyxoah's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore how well can Nyxoah service its debt to assess how comfortably operating cash covers total debt obligations.

Nyxoah Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nyxoah ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Rayence Co. Ltd KQ:228850	0.022x
Aquila European Renewables Income PLC LSE:AERI	0.005x
Gseven Co Ltd TWO:2937	0.104x
Broadway Financial Corporation NASDAQ:BYFC	0.004x
Tsann Kuen Enterprise Co Ltd TW:2430	0.135x
Making Science Group S.A. MC:MAKS	0.767x
A-Jin Industry Co Ltd KQ:013310	-0.060x
Tomei Consolidated Bhd KLSE:7230	0.049x

Annual Cash Flow Conversion Efficiency for Nyxoah (2017–2024)

The table below shows the annual cash flow conversion efficiency of Nyxoah from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see Nyxoah (NYXH) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€113.25 Million ≈ $132.41 Million	€-49.23 Million ≈ $-57.55 Million	-0.435x	+4.85%
2023-12-31	€98.02 Million ≈ $114.60 Million	€-44.78 Million ≈ $-52.35 Million	-0.457x	-91.15%
2022-12-31	€120.32 Million ≈ $140.67 Million	€-28.76 Million ≈ $-33.62 Million	-0.239x	-40.19%
2021-12-31	€148.62 Million ≈ $173.75 Million	€-25.34 Million ≈ $-29.62 Million	-0.170x	-141.38%
2020-12-31	€97.19 Million ≈ $113.63 Million	€-6.86 Million ≈ $-8.02 Million	-0.071x	+95.58%
2019-12-31	€3.71 Million ≈ $4.34 Million	€-5.93 Million ≈ $-6.94 Million	-1.598x	-105.20%
2018-12-31	€10.45 Million ≈ $12.22 Million	€-8.14 Million ≈ $-9.52 Million	-0.779x	+57.47%
2017-12-31	€4.53 Million ≈ $5.29 Million	€-8.29 Million ≈ $-9.69 Million	-1.831x	--

About Nyxoah

BR:NYXH Belgium Medical Instruments & Supplies

Market Cap

$62.38 Million

€53.35 Million EUR

Market Cap Rank

#20917 Global

#91 in Belgium

Share Price

€1.24

Change (1 day)

-0.48%

52-Week Range

€1.24 - €7.28

All Time High

€29.90